The Relationship Among Atrium Electromechanical Interval, Insulin Resistance, and Metabolic Syndrome

Abstract Background Metabolic syndrome (MS) is an important risk factor of atrial fibrillation. However, an understanding of the adverse effects of MS on left atrial (LA) functional assessment in terms of electromechanical interval, a convenient parameter that can reflect the process of LA remodelli...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Canadian journal of cardiology 2013-10, Vol.29 (10), p.1263-1268
Hauptverfasser: Hung, Chung-Lieh, MD, Chao, Tze-Fan, MD, Lai, Yau-Huei, MD, Yen, Chih-Hsuan, MD, Wang, Kang-Ling, MD, Tsao, Hsuan-Ming, MD, Lin, Yenn-Jiang, MD, Chang, Shih-Lin, MD, Lo, Li-Wei, MD, Hu, Yu-Feng, MD, Kuo, Jen-Yuan, MD, Yeh, Hung-I., MD, PhD, Chen, Shih-Ann, MD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Abstract Background Metabolic syndrome (MS) is an important risk factor of atrial fibrillation. However, an understanding of the adverse effects of MS on left atrial (LA) functional assessment in terms of electromechanical interval, a convenient parameter that can reflect the process of LA remodelling, has been lacking. The goal of this study was to investigate the association between electromechanical interval and MS. Methods In all, 337 patients (91 with MS) with mean age of 51.9 ± 9.0 years were enrolled. Metabolic syndrome was defined by National Cholesterol Education Program–Adult Treatment Panel III score. Insulin resistance was assessed by the homeostasis model assessment–insulin resistance method. The electromechanical interval, defined as the time from initiation of P wave deflection to peak of mitral inflow Doppler A wave (PA-PDI), was measured. Results Patients with MS had significantly longer PA-PDI intervals compared with those of patients without MS (131.0 ± 12.4 milliseconds vs 123.2 ± 14.0 milliseconds, P < 0.001). Longer PA-PDI intervals were observed in subjects with higher metabolic scores ( P <  0.05). In patients with small LA size, PA-PDI intervals, but not LA dimensions, were significantly different between groups with and without MS ( P < 0.05). Additionally, PA-PDI interval was positively correlated with insulin resistance ( r  = 0.267, P < 0.001). Conclusions PA-PDI intervals were longer in patients with MS compared with those of patients without MS and tracked with insulin resistance. PA-PDI may be a useful clinical parameter to represent the degree of atrial remodelling in subjects with metabolic derangements.
ISSN:0828-282X
1916-7075
DOI:10.1016/j.cjca.2013.01.001